Trial intelligence / Profile preview

Belatacept vs Tacrolimus with Early Steroid Withdrawal in Renal Transplantation

NCT01729494Phase 4Completed

Sponsor
University of Cincinnati
Start
Sep 2012
Primary completion
Dec 2018
Modality
Fc-Fusion Proteins
Countries
1
01

Overview

A Phase 4 trial of belatacept in kidney transplant rejection, sponsored by University of Cincinnati. Started Sep 2012; status: completed.

02

Drugs

belatacept
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT01729494.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01729494.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call